ARTICLE | Financial News
Jounce debuts with $47M
February 15, 2013 1:47 AM UTC
Jounce Therapeutics Inc. (Cambridge, Mass.) debuted on Thursday with $47 million in a series A round from Third Rock Ventures to develop cancer immunotherapies. Interim CEO Cary Pfeffer said Jounce in...